1
|
Lawler M, Le Chevalier T, Murphy MJ, Banks I, Conte P, De Lorenzo F, Meunier F, Pinedo H, Selby P, Armand JP, Barbacid M, Barzach M, Bergh J, Bode G, Cameron DA, de Braud F, de Gramont A, Diehl V, Diler S, Erdem S, Fitzpatrick JM, Geissler J, Hollywood D, Højgaard L, Horgan D, Jassem J, Johnson PW, Kapitein P, Kelly J, Kloezen S, La Vecchia C, Löwenberg B, Oliver K, Sullivan R, Tabernero J, Van de Velde CJ, Wilking N, Wilson R, Zielinski C, zur Hausen H, Johnston PG. A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist 2014; 19:217-24. [PMID: 24493667 PMCID: PMC3958470 DOI: 10.1634/theoncologist.2013-0452] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2013] [Accepted: 01/06/2014] [Indexed: 11/17/2022] Open
Abstract
The European Cancer Concord is a unique patient-centered partnership that will act as a catalyst to achieve improved access to an optimal standard of cancer care and research for European citizens. In order to provide tangible benefits for European cancer patients, the partnership proposes the creation of a “European Cancer Patient’s Bill of Rights,” a patient charter that will underpin equitable access to an optimal standard of care for Europe’s citizens.
Collapse
Affiliation(s)
- Mark Lawler
- Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, United Kingdom
| | | | - Martin J. Murphy
- European Cancer Concord, Society for Translational Oncology, Durham, North Carolina, USA
| | - Ian Banks
- European Men’s Health Forum, Brussels, Belgium
| | | | - Francesco De Lorenzo
- Italian Federation of Volunteer-based Cancer Organizations, Rome, Italy
- European Cancer Patient Coalition, Brussels, Belgium
| | - Françoise Meunier
- European Organisation for Research and Treatment of Cancer, Brussels, Belgium
| | - H.M. Pinedo
- VuMC Cancer Center, Amsterdam, The Netherlands
| | - Peter Selby
- Department of Medical Oncology, University of Leeds, Leeds, United Kingdom
| | | | | | | | - Jonas Bergh
- Department of Oncology-Pathology, Karolinska Institut, Stockholm, Sweden
| | - Gerlind Bode
- International Confederation of Childhood Cancer Parent Organizations, Nieuwegein, The Netherlands
| | - David A. Cameron
- Edinburgh Cancer Centre, NHS Lothian & Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
| | - Filippo de Braud
- Medical Oncology Division, National Cancer Institute, Milan, Italy
| | | | - Volker Diehl
- Internal Medicine, University of Cologne, Köln, Germany
| | | | - Sema Erdem
- Europa Donna, Piazza Amendola, Milan, Italy
| | - John M. Fitzpatrick
- Irish Cancer Society, Dublin, Ireland
- Department of Surgery, University College Dublin, Dublin, Ireland
| | - Jan Geissler
- Leukemia Patient Advocates Foundation, Berne, Switzerland
- European Patients Academy on Therapeutic Innovation, Riemerling, Germany
| | - Donal Hollywood
- >† Deceased
- Academic Unit of Clinical and Molecular Oncology, St James’s Hospital and Trinity College Dublin, Dublin, Ireland
| | - Liselotte Højgaard
- Danish National Research Foundation, Copenhagen, Denmark
- Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
| | - Denis Horgan
- European Alliance for Personalised Medicine, Brussels, Belgium
| | - Jacek Jassem
- Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
| | - Peter W. Johnson
- Department of Medical Oncology, University of Southampton, Southampton, United Kingdom
- Cancer Research UK, London, United Kingdom
| | | | - Joan Kelly
- Irish Cancer Society, Dublin, Ireland
- European Cancer Leagues, Brussels, Belgium
| | | | - Carlo La Vecchia
- Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche “Mario Negri” Milan, Italy
| | - Bob Löwenberg
- Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Kathy Oliver
- International Brain Tumor Alliance, Tadworth, Surrey, United Kingdom
| | - Richard Sullivan
- Institute of Cancer Policy, Kings Health Partners Integrated Cancer Centre, London, United Kingdom
| | | | | | - Nils Wilking
- Department of Oncology, Karolinska Institut, Stockholm, Sweden, and Skåne University Hospital, Lund, Sweden
| | | | - Christoph Zielinski
- Comprehensive Cancer Center and Department of Medicine I, Medical University Vienna - General Hospital, Vienna, Austria
| | - Harald zur Hausen
- German Cancer Research Centre, University of Heidelberg, Heidelberg, Germany
| | - Patrick G. Johnston
- Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, United Kingdom
- School of Medicine, Dentistry and Biomedical Sciences, and Institute of Health Sciences, Queens University Belfast, Belfast, United Kingdom
| |
Collapse
|